Securities code: Jafron Biomedical Co.Ltd(300529) securities abbreviation: Jafron Biomedical Co.Ltd(300529) Announcement No.: 2022043 bond Code: 123117 bond abbreviation: Jianfan convertible bond
Jafron Biomedical Co.Ltd(300529)
Suggestive announcement on the disclosure of the first quarter report of 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
On April 13, 2022, Jafron Biomedical Co.Ltd(300529) (hereinafter referred to as “the company”) held the 34th meeting of the 4th board of directors and the 32nd meeting of the 4th board of supervisors, and deliberated and adopted the full text of the company’s first quarter report of 2022.
In order to enable investors to fully understand the company’s operating results, the full text of the company’s first quarter report of 2022 will be published on cninfo.com, the gem information disclosure website designated by the CSRC on April 14, 2022（ http://www.cn.info.com.cn. ）Please pay attention to the disclosure.
It is hereby announced.
Jafron Biomedical Co.Ltd(300529) board of directors April 14, 2022
